Geoffrey von Maltzahn
Co-Founder, Chief Innovation Officer, and Director, Indigo Ag
Geoffrey is co-founder and Chief Innovation Officer for Indigo, as well as a Partner at Flagship Pioneering, where he focuses on inventing technologies and starting companies to address global challenges in nutrition, environmental sustainability, and medicine. He is also a co-founder of Seres Therapeutics (NASDAQ:MCRB), Kaleido Biosciences, Sienna Biopharmaceuticals (NASDAQ:SNNA), Axcella Health and others.
-
Going Beyond the Gut: The Future of Microbiome Therapeutics
Partner:MIT Enterprise Forum Cambridge